Sharon Mates - Chairman, Intra-Cellular Therapies, Inc

As of January 11, 2022


Sharon Mates Net Worth

  • Net worth is estimated to be at least $66.09M
  • Owns at least 1,094,467 units of Intra-Cellular Therapies, Inc stock
  • Sold an estimated value of $18.25M in the last 8 years at Intra-Cellular Therapies, Inc

Sharon Mates Compensation at Intra-Cellular Therapies, Inc in 2020

  • Earned a $766,800 salary and a $690 bonus
  • Rewarded $2,799,998 in stock value and options
  • Received a total compensation of $5,475,679

Sharon Mates Trading

  • Largest purchase of shares was 101,895 units , worth over $164.4K on January 8, 2020
  • Largest sale of shares was 51,500 units , worth over $2.77M on December 15, 2015
  • In total has made about 28 transactions over 8 years
  • Usually trades in January, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Sharon Mates Mailing Address

  • Mailing address is C/o Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032 NY

Intra-Cellular Therapies, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Sharon Mates, Ph.D. 2020 $766,800 $690,120 $2,799,998 $1,199,994 $18,767 $5,475,679
Sharon Mates, Ph.D. 2019 $744,500 $759,400 $1,599,996 $1,600,003 $20,661 $4,724,560
Sharon Mates, Ph.D. 2018 $722,800 $585,500 $1,593,735 $1,556,410 $18,024 $4,476,469
Lawrence J. Hineline 2020 $463,400 $222,432 $1,049,984 $449,993 $20,374 $2,206,183
Lawrence J. Hineline 2019 $449,900 $225,000 $749,988 $749,995 $18,648 $2,193,531
Lawrence J. Hineline 2018 $424,400 $203,700 $749,986 $732,430 $17,292 $2,127,808
Suresh Durgam, M.D. 2020 $448,575 $274,400 $599,984 $599,997 $7,385 $1,930,341
Michael I. Halstead 2020 $512,000 $320,000 $1,119,985 $479,990 $17,931 $2,449,906
Michael I. Halstead 2019 $497,100 $323,100 $749,988 $749,995 $17,270 $2,337,453
Michael I. Halstead 2018 $469,000 $225,100 $749,986 $732,430 $16,680 $2,193,196
Mark Neumann 2020 $518,900 $324,312 $1,119,985 $479,990 $130,085 $2,573,272
Mark Neumann 2019 $503,800 $277,100 $799,991 $799,997 $133,449 $2,514,337
Mark Neumann 2018 $106,090 $245,500 $749,995 $749,990 $25,124 $1,876,699
Andrew Satlin, M.D. 2020 $480,634 $0 $1,119,985 $479,990 $20,585 $2,101,194
Andrew Satlin, M.D. 2019 $515,000 $360,500 $874,997 $874,996 $19,332 $2,644,825
Andrew Satlin, M.D. 2018 $500,000 $300,000 $0 $0 $11,792 $811,792
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm

Intra-Cellular Therapies, Inc Insider Trading

  • The most recent transaction was 6,870 units sold on January 11, 2022 by Suresh Durgam worth over $280.02K
  • In the last 8 years, insiders at Intra-Cellular Therapies, Inc sold an estimated value of $69.75M and bought an estimated value of $60.16M
  • The most active traders are Christopher Alafi, Director,  Richard Lerner, Director,  and Rory Riggs, Director
  • Insider trading is most common in January, with the busiest year in 2020

Intra-Cellular Therapies, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1